OraSure Technologies Announces 2022 Annual Meeting Date
14 12월 2021 - 9:05PM
OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its
2022 Annual Meeting of Stockholders is scheduled to be held at
10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 17, 2022. The record
date for the Meeting will be March 27, 2022. Only stockholders of
record as of the close of business on the record date will be
entitled to vote at the 2022 Annual Meeting, or any adjournment(s)
or postponement(s) of the Meeting. This will be a completely
virtual meeting, conducted as a live webcast. Further details
regarding the Meeting will be provided at a later date.
About OraSure Technologies
OraSure Technologies empowers the global
community to improve health and wellness by providing access to
accurate, essential information. OraSure, together with its wholly
owned subsidiaries, DNA Genotek, Diversigen, and Novosanis,
provides its customers with end-to-end solutions that encompass
tools, services and diagnostics. The OraSure family of companies is
a leader in the development, manufacture, and distribution of rapid
diagnostic tests, sample collection and stabilization devices, and
molecular services solutions designed to discover and detect
critical medical conditions. OraSure’s portfolio of products is
sold globally to clinical laboratories, hospitals, physician’s
offices, clinics, public health and community-based organizations,
research institutions, government agencies, pharma, commercial
entities and direct to consumers. For more information on OraSure
Technologies, please visit www.orasure.com.
For more information on OraSure Technologies,
please visit www.orasure.com.
Investor
Contact: Scott
Gleason Interim
CFO, SVP Investor Relations & Corporate
Communications 484-425-0588 sgleason@orasure.com |
Media Contact:Amy KochSenior Manager Corporate
Communications484-523-1815media@orasure.com |
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024